The health secretary has advocated for deregulating more peptides, but FDA scientists point to a lack of data about their ...
Koi Peptides (Koi Research Labs LLC) has introduced Klow Peptide Stack as a research-use-only multi-peptide blend for laboratory research in 2026. The product contains GHK-Cu, BPC-157, TB-500, and KPV ...
By Sneha S K June 30 (Reuters) - The U.S. Food and Drug Administration's staff reviewers said available evidence does not ...
Kennedy Jr. has stacked another federal advisory panel with allies, advancing his efforts to force the Food and Drug ...
By Sneha S K June 30 (Reuters) - U.S. FDA staff reviewers said there is little evidence to allow compounding pharmacies to ...
The all-in-one platform helps entrepreneurs, clinics, med spas, gyms, and wellness brands launch cash-pay telehealth programs ...
Hone Health reports that 50% of peptide users mistakenly believe they take FDA-approved compounds, highlighting risks of ...
Committee will meet in July to discuss peptides now sold in gray market despite limited evidence of safety and efficacy ...
Think peptides like BPC-157 are fully legal again in 2026? Here's what RFK Jr.'s plan still needs before that's actually true.
MedPage Today on MSN
FDA Scientists Raise Peptide Concerns Ahead of Committee Meeting
RFK Jr. recently added peptide-friendly members to a key panel ...
FDA revamps peptide panel by appointing wellness clinic physicians to advise on pharmacy compounding of seven peptides, including BPC-157 and TB-500.
The stock is already showing accelerating fundamentals (33% LTM revenue growth, 73% gross margin) plus credible weight-loss distribution via Novo Nordisk’s largest telehealth partner. The market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results